Here’s Why Artisan Small Cap Purchased Array Technologies (ARRY)
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded...
Posts Tagged ‘NASDAQ:ARRY’
Baron Funds Remains Optimistic in Array Technologies (ARRY), Here’s Why
Baron Funds, an asset management firm, published its “Baron Small Cap Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.
10 Best New Stocks To Buy Now
In this article, we shared the 10 best new stocks to buy now.
Here is What Hedge Funds Think About Array Biopharma Inc (ARRY)
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Did Hedge Funds Drop The Ball On Array Biopharma Inc (ARRY) ?
The Insider Monkey team has completed processing the quarterly 13F filings for the December quarter submitted by the hedge funds and other money managers included in our extensive...
Is Array Biopharma Inc (ARRY) A Good Stock To Buy?
The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed...
Market Movers Today: FirstEnergy Corp (FE), Juno Therapeutics Inc (JUNO), Halliburton Company (HAL), and More
What happened: Shares of First Energy (NYSE:FE) spiked on Monday and were up 15% at 10:45 a.m.
13G Filing: Point72 Asset Management and Array Biopharma Inc (ARRY)
Please follow Point72 Asset Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Point72 Asset Management or update its...
Wondering What’s Happening in the Financial Markets Today? Check Out These 31 Stories!
"U.S. stocks edged lower on Tuesday as weakness in the energy and financial sectors outweighed gains in technology shares.
Wondering What’s Going On in the Financial Markets Today? Check Out These 36 Stories!
"U.S. stocks wavered on Wednesday as investors digested a batch of weak corporate earnings and President Donald Trump's dismissal of his FBI chief. At 1:59 p.m.
Apple, Array Biopharma, Alaska Air, and More: Here’s Why These Five Stocks Are in the Spotlight
It's the beginning of a new week and the three major indexes look once again to open relatively flat. Although the U.K.
Is Array Biopharma Inc (ARRY) A Good Stock To Buy?
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that...
Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks?
Despite of all the negative sentiment looming around them, hedge funds had a pretty solid run for much of this year, generating positive returns for seven or eight consecutive...
Array Biopharma Inc (ARRY) Updates On COLUMBUS Phase 3 And It’s Impressive
Array Biopharma Inc (NASDAQ:ARRY) and its partner Pierre Fabre took the opportunity at the Society for Melanoma Research Annual Congress to share results for its COLUMBUS Phase...
Array Biopharma Inc (ARRY) Stock: Gaining Big On Clinical Data
Today is likely to be a very interesting day in the market following the Trump win. Nonetheless, Array Biopharma Inc (NASDAQ:ARRY) is skyrocketing, and for good reason.
Why Wells Fargo, Select Comfort, Array Biopharma, American Express, and More Are Trending
In this article, we'll find out why investors are buzzing about two big Warren Buffett favorites, along with three other companies.
ProNAi Therapeutics Inc. (DNAI), Ballard Power Systems Inc. (USA) (BLDP) & More: Major Hype Surrounding These Stocks Today
The markets are buoyant today after a report showcased a rise in US Consumer Confidence.
Why Investors Are Buzzing About Yum, Twitter, GM, RetailMeNot, and Array Biopharma Today
It's a red day on Wall Street, as all three major indexes are lower.
Why Sarepta, Glu Mobile, Harmony Gold and 2 Other Stocks Are On The Move Today
Some stocks are nonetheless gaining ground this morning, including Sarepta Therapeutics Inc (NASDAQ:SRPT), At Home Group Inc.
What Are Array Biopharma Inc (ARRY)’s Chances Of PDUFA Success?
Array Biopharma Inc (NASDAQ:ARRY) just had its latest NDA accepted by the FDA, and the agency has put forward a PDUFA date for the candidate of June 30, 2017.
Why These Stocks Are Trending on Friday
Investors are keenly watching some stocks today, including Micron Technology, Inc. (NASDAQ:MU), Vale SA (ADR) (NYSE:VALE), Transocean LTD (NYSE:RIG), Himax Technologies, Inc.
All You Need To Know About Array Biopharma Inc (ARRY)’s Upcoming NDA Submission
Array Biopharma Inc (NASDAQ:ARRY) just reported detailed topline from a recently completed oncology pivotal, and alongside the report, announced it expects to submit a New Drug...
Redmile Group Sticking With Healthcare Picks After Rough Q1
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience in wealth management...
Most Popular Healthcare Stocks Under $5
Most securities that cost less than a dinner at a fast-food restaurant are considered to be too risky, with most intra-day traders or other investors usually avoiding these low...
Five Cheap Healthcare Stocks With Hedge Fund Support
When it comes to the risk-reward ratio, there are very few sectors which can match up to healthcare.
Billionaires James Flynn, David Abrams, Among the Elite Investors Buying These 4 Stocks Last Week
Individual investors might find hedge fund investing quite expensive, considering the 2-and-2o fee structure most hedge funds employ.
Buffett, Starboard Among the Elite Investors to Disclose New Moves
The deadline for the current round of 13F filings, for the quarterly period that ended December 31, is February 15.
Why Are These Stocks Trending Today?
It's Wednesday and the S&P 500 futures are still firmly in the green in pre-market trading despite the fact that the Federal Reserve is set to raise rates in its FOMC meeting ...
Is Array Biopharma Inc (ARRY) a Good Stock To Buy?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers...
Redmile Group Continues To Agressively Buy Shares Of This Biotech
Correction: This article has previously mistakenly stated that the Redmile Group had sold shares of Array Biopharma.
Redmile Group Fortifies Position In Array Biopharma Inc (ARRY); Broadwood Capital Boosts Stake In STAAR Surgical Company (STAA)
Jeremy Green, the manager of Redmile Group, is still bullish on Array Biopharma Inc (NASDAQ:ARRY) having further increased his holding of the stock.
Redmile Group Is Putting More Money Into Array BioPharma Inc. (ARRY)
Jeremy Green’s Redmile Group has just acquired more shares of Array BioPharma Inc. (NASDAQ:ARRY). In a Form 4 filed with the U.S.
One Of Mark Lampert’s Small-Cap Biotech Picks Has Returned 84% This Year And It’s Not Done Yet
Mark Lampert’s Biotechnology Value Fund recently filed its 13F with the U.S. Securities and Exchange Commission for the reporting period of March 31.
Should You Buy Optimer Pharmaceuticals, Inc. (OPTR)?
At the moment, there are plenty of metrics investors can use to track their holdings. Two of the most under-the-radar are hedge fund and insider trading interest.
Hedge Funds Are Dumping EXACT Sciences Corporation (EXAS)
In the financial world, there are a multitude of gauges shareholders can use to analyze Mr. Market. Two of the most innovative are hedge fund and insider trading interest.
Hedge Funds Are Buying ACADIA Pharmaceuticals Inc. (ACAD)
In the eyes of many of your fellow readers, hedge funds are viewed as overrated, outdated financial tools of a forgotten age.
Array Biopharma Inc (ARRY): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most innovative are hedge fund and insider trading sentiment.
Array Biopharma Inc (ARRY), Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Three Ways Your Kids Can Be Harmed by Smog
Around four in 10 Americans live in places where smog can impact their health.
Array Biopharma Inc (ARRY), AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): This Cancer Biotech Is Looking for Other Green Pastures
Array Biopharma Inc (NASDAQ:ARRY), a biotech company primarily focused on discovery of drugs for cancer treatment, is making forays into the asthma market.
Array Biopharma Inc (ARRY), Vertex Pharmaceuticals Incorporated (VRTX): This Week in Biotech
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Array Biopharma Inc (ARRY), InterMune Inc (ITMN): Three Humongous Health-Care Stocks This Week
The study included 184 patients with mild-to-moderate persistent allergic asthma.
Is Merrimack Pharmaceuticals Inc (MACK) Going to Burn These Hedge Funds?
According to most shareholders, hedge funds are seen as slow, old financial vehicles of the past.
Hedge Funds Are Dumping Optimer Pharmaceuticals, Inc. (OPTR)
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) was in 11 hedge funds' portfolio at the end of March. OPTR investors should be aware of a decrease in hedge fund interest lately.
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS): All About ASCO – 2013 Highlights
Every week at The Motley Fool we reflect on the top stories in the biotech sector in a wrap-up column.
Is Array Biopharma Inc (ARRY) Going to Burn These Hedge Funds?
If you'd ask most shareholders, hedge funds are seen as slow, old investment vehicles of the past.
Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD)
To most market participants, hedge funds are viewed as underperforming, outdated financial vehicles of the past.
Should You Avoid ACADIA Pharmaceuticals Inc. (ACAD)?
To most traders, hedge funds are seen as unimportant, outdated investment tools of the past.
Ariad Pharmaceuticals, Inc. (ARIA) Among The Biotech Players To Watch
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) is on the focused approach trajectory, using its solid foundation in the sciences to fill the holes left open by big pharma. Celldex...
Should You Avoid Merrimack Pharmaceuticals Inc (MACK)?
To the average investor, there are a multitude of gauges investors can use to monitor their holdings.
